Dade adds plasma-protein to Premier deal:
This article was originally published in Clinica
Dade Behring and Premier, the US hospital buying group, have agreed to add the instruments and assays for plasma-protein testing to their clinical chemistry contract, signed last year. The quantitative automated nephelometry tests can diagnose and monitor various disease states, including cardiovascular risk, rheumatic, chronic and acute inflammatory diseases, renal function and iron metabolism.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.